Herbal decoction added to vessel treatment for diabetic foot ulcers
Tests Modified Simiao Yongan Decoction with standard care in adults with diabetic foot ulcers.
Key facts
- Who runs it
- Chengdu University of Traditional Chinese Medicine
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Clinical Efficacy of Modified Simiao Yongan Decoction and Endovascular Therapy for Diabetic Foot Ulcers
- Status
- Not yet recruiting
- People taking part
- 120 people, planned
- Starts
- Dec 2026
- Expected to end
- Nov 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Modified Simiao Yongan Decoction
- Endovascular Therapy and Standard Care
- Record updated
- 8 September 2026
Who can take part
The trial is looking for adults with a diabetic foot ulcer who have already had a successful procedure to open leg blood vessels from the inside (endovascular intervention). They must also show the Traditional Chinese Medicine pattern called "Damp-Heat Toxins Accumulation Syndrome".
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- Diabetic foot ulcer, Rutherford classification 4-5 or Wagner classification 2-4. The person needs at least two main signs, such as a red, swollen, hot or painful limb. They also need at least one minor sign, such as a dry mouth or a red tongue with a yellow coating.
- Earlier treatment
- Must have successfully received a lower extremity endovascular intervention.
- Main reasons for not taking part
- Severe, uncontrolled life-threatening disease, such as severe heart failure (NYHA class III-IV), severe liver or kidney problems, or active cancer
- Active sepsis (blood infection), extensive gangrene, or severe bone infection needing immediate major amputation of the limb
- Allergy or severe reaction to any herb in the Modified Simiao Yongan Decoction
- Pregnant, planning pregnancy, or breastfeeding
- Taking part in another interventional clinical trial now or within the last 30 days
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Diagnosed with a Diabetic Foot Ulcer (DFU)
- Assessed as Rutherford classification 4-5 or Wagner classification 2-4
- Successfully received lower extremity endovascular intervention
- Meets the Traditional Chinese Medicine diagnostic criteria for "Damp-Heat Toxins Accumulation Syndrome". Patients must exhibit at least two primary symptoms (red/swollen/hot/painful limb, high exudate or purulent secretion with foul odor, dark purple wound/necrotic tissue, elevated local skin temperature) and at least one secondary symptom (dry mouth/bitter taste, dry stool, red tongue with yellow greasy coating, rapid/string-taut pulse)
Who cannot take part
- Patients with severe, uncontrolled life-threatening systemic diseases, such as severe heart failure (NYHA class III-IV), severe hepatic or renal dysfunction, or active malignancy
- Patients with known allergies, hypersensitivity, or severe adverse reactions to any of the herbal components of the Modified Simiao Yongan Decoction
- Patients with severe gastrointestinal disorders that would significantly impair the absorption of oral medications
- Patients with severe cognitive impairment, psychiatric disorders, or poor compliance that would prevent them from providing informed consent or adhering to the 24-month follow-up schedule
- Patients with active systemic sepsis, extensive gangrene, or severe osteomyelitis requiring immediate major amputation of the target limb
- Women who are pregnant, planning to become pregnant, or currently lactating
- Patients currently participating in, or who have participated in within the last 30 days, another interventional clinical trial
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Diabetic foot ulcer or damp-heat toxins accumulation syndrome
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study evaluates the clinical efficacy and safety of a Modified Simiao Yongan Decoction when used alongside standard endovascular therapy and wound care for the treatment of diabetic foot ulcers. The trial focuses on patients presenting with the damp-heat toxins accumulation syndrome (Rutherford 4-5 or Wagner 2-4 classifications). Enrolling 120 participants, the study aims to observe the complete ulcer healing rate, limb salvage outcomes, and improvements in patient quality of life over a 6 to 24-month follow-up period.
The 2 groups in the trial
- Experimental GroupTreatment being tested
Participants in this group will undergo standard endovascular intervention, receive a standardized antithrombotic regimen, and undergo standard wound care. In addition, they will receive a 1-month course of Modified Simiao Yongan Decoction granules.
Treatment: Modified Simiao Yongan Decoction and Endovascular Therapy and Standard Care
- Standard Treatment Control GroupExisting treatment, for comparison
Participants in this group will undergo standard endovascular intervention, receive a standardized antithrombotic regimen, and undergo standard wound care without the addition of the herbal granules.
Treatment: Endovascular Therapy and Standard Care
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Efficacy and Mechanism of Modified Simiao Yongan Decoction Combined With Endovascular Therapy for Diabetic Foot Ulcers (Damp-Heat Toxins Accumulation Syndrome) Based on the Vascular-Immune Microenvironment
- Plain-language title
- Herbal decoction added to vessel treatment for diabetic foot ulcersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07808502, who can take part
- Record updated
- 8 September 2026